compounded semaglutide update FDA Warns on Certain Forms of Personalized Compounded Semaglutide | Alan

doi: 10.1097/01.RVI.0000108687.75691.0C

Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia

GLP-1 medications are safe for most people when prescribed and monitored by a healthcare professional

Because tirzepatide (brand name Mounjaro) was only approved by the FDA in mid-2022 for type 2 diabetes, the ability to rigorously analyze its use (on- and off-label) for a broad population of patients with overweight or obesity, not just a subset captured in insurance databases, has the power to greatly improve our understanding of how these agents are being used in every day practice and the effect that theyre having.